Treatment of bilateral cytomegalovirus retinitis with sustained-release ganciclovir implants in a child.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8909217.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To report treatment of bilateral cytomegalovirus (CMV) retinitis in an 11-year-old girl with acquired immunodeficiency syndrome (AIDS). Case report describing the use of intravitreal ganciclovir sustained-release devices to treat CMV retinitis, involving zones 1 through 3, which progressed despite single and combination intravenous therapy with ganciclovir and foscarnet. Stabilization with no active CMV retinitis was achieved after bilateral implantation of intravitreal sustained-release ganciclovir devices. There was no reactivation of the retinitis during the 5 months of follow-up. Sustained-release ganciclovir implants can be used to achieve local control of CMV retinitis in the pediatric patient.
Medical subject headings
- AIDS-Related Opportunistic Infections
- Antiviral Agents
- Cytomegalovirus Retinitis
- Ganciclovir